164 related articles for article (PubMed ID: 35925880)
21. Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors.
Richters A; Doyle SK; Freeman DB; Lee C; Leifer BS; Jagannathan S; Kabinger F; Koren JV; Struntz NB; Urgiles J; Stagg RA; Curtin BH; Chatterjee D; Mathea S; Mikochik PJ; Hopkins TD; Gao H; Branch JR; Xin H; Westover L; Bignan GC; Rupnow BA; Karlin KL; Olson CM; Westbrook TF; Vacca J; Wilfong CM; Trotter BW; Saffran DC; Bischofberger N; Knapp S; Russo JW; Hickson I; Bischoff JR; Gottardis MM; Balk SP; Lin CY; Pop MS; Koehler AN
Cell Chem Biol; 2021 Feb; 28(2):134-147.e14. PubMed ID: 33086052
[TBL] [Abstract][Full Text] [Related]
22. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
23. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
Fujinaga K; Irwin D; Geyer M; Peterlin BM
J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
[TBL] [Abstract][Full Text] [Related]
24. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
Baumli S; Lolli G; Lowe ED; Troiani S; Rusconi L; Bullock AN; Debreczeni JE; Knapp S; Johnson LN
EMBO J; 2008 Jul; 27(13):1907-18. PubMed ID: 18566585
[TBL] [Abstract][Full Text] [Related]
25. Physical interaction between pRb and cdk9/cyclinT2 complex.
Simone C; Bagella L; Bellan C; Giordano A
Oncogene; 2002 Jun; 21(26):4158-65. PubMed ID: 12037672
[TBL] [Abstract][Full Text] [Related]
26. The role of the Cdk9/Cyclin T1 complex in T cell differentiation.
Leucci E; De Falco G; Onnis A; Cerino G; Cocco M; Luzzi A; Crupi D; Tigli C; Bellan C; Tosi P; Leoncini L; Giordano A
J Cell Physiol; 2007 Aug; 212(2):411-5. PubMed ID: 17352406
[TBL] [Abstract][Full Text] [Related]
27. Cyclins that don't cycle--cyclin T/cyclin-dependent kinase-9 determines cardiac muscle cell size.
Sano M; Schneider MD
Cell Cycle; 2003; 2(2):99-104. PubMed ID: 12695656
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of cyclin T1/CDK9 complexes during T cell activation.
Garriga J; Peng J; Parreño M; Price DH; Henderson EE; Graña X
Oncogene; 1998 Dec; 17(24):3093-102. PubMed ID: 9872325
[TBL] [Abstract][Full Text] [Related]
29. In silico design of small molecule inhibitors of CDK9/cyclin T1 interaction.
Randjelovic J; Eric S; Savic V
J Mol Graph Model; 2014 May; 50():100-12. PubMed ID: 24769691
[TBL] [Abstract][Full Text] [Related]
30. Cdk9/Cyclin T1 complex: a key player during the activation/differentiation process of normal lymphoid B cells.
De Falco G; Leucci E; Onnis A; Bellan C; Tigli C; Wirths S; Cerino G; Cocco M; Crupi D; De Luca A; Lanzavecchia A; Tosi P; Leoncini L; Giordano A
J Cell Physiol; 2008 Apr; 215(1):276-82. PubMed ID: 18205180
[TBL] [Abstract][Full Text] [Related]
31. Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy.
Sano M; Abdellatif M; Oh H; Xie M; Bagella L; Giordano A; Michael LH; DeMayo FJ; Schneider MD
Nat Med; 2002 Nov; 8(11):1310-7. PubMed ID: 12368904
[TBL] [Abstract][Full Text] [Related]
32. CDK9 inhibition activates innate immune response through viral mimicry.
Yalala S; Gondane A; Poulose N; Liang J; Mills IG; Itkonen HM
FASEB J; 2024 Apr; 38(8):e23628. PubMed ID: 38661032
[TBL] [Abstract][Full Text] [Related]
33. The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions.
Herrmann CH; Mancini MA
J Cell Sci; 2001 Apr; 114(Pt 8):1491-503. PubMed ID: 11282025
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation.
Olson CM; Jiang B; Erb MA; Liang Y; Doctor ZM; Zhang Z; Zhang T; Kwiatkowski N; Boukhali M; Green JL; Haas W; Nomanbhoy T; Fischer ES; Young RA; Bradner JE; Winter GE; Gray NS
Nat Chem Biol; 2018 Feb; 14(2):163-170. PubMed ID: 29251720
[TBL] [Abstract][Full Text] [Related]
35. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
[TBL] [Abstract][Full Text] [Related]
36. The CDK9/cyclin T1 subunits of P-TEFb in mouse oocytes and preimplantation embryos: a possible role in embryonic genome activation.
Oqani RK; Kim HR; Diao YF; Park CS; Jin DI
BMC Dev Biol; 2011 Jun; 11():33. PubMed ID: 21639898
[TBL] [Abstract][Full Text] [Related]
37. Role of cyclinT/Cdk9 complex in basal and regulated transcription (review).
Napolitano G; Majello B; Lania L
Int J Oncol; 2002 Jul; 21(1):171-7. PubMed ID: 12063565
[TBL] [Abstract][Full Text] [Related]
38. Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure.
Sano M; Wang SC; Shirai M; Scaglia F; Xie M; Sakai S; Tanaka T; Kulkarni PA; Barger PM; Youker KA; Taffet GE; Hamamori Y; Michael LH; Craigen WJ; Schneider MD
EMBO J; 2004 Sep; 23(17):3559-69. PubMed ID: 15297879
[TBL] [Abstract][Full Text] [Related]
39. Recruitment of cdk9 to the immediate-early viral transcriptosomes during human cytomegalovirus infection requires efficient binding to cyclin T1, a threshold level of IE2 86, and active transcription.
Kapasi AJ; Clark CL; Tran K; Spector DH
J Virol; 2009 Jun; 83(11):5904-17. PubMed ID: 19297489
[TBL] [Abstract][Full Text] [Related]
40. Targeting CDK9: a promising therapeutic opportunity in prostate cancer.
Rahaman MH; Kumarasiri M; Mekonnen LB; Yu M; Diab S; Albrecht H; Milne RW; Wang S
Endocr Relat Cancer; 2016 Dec; 23(12):T211-T226. PubMed ID: 27582311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
